New era of Idiopathic Pulmonary Fibrosis

Respir Investig. 2018 Nov;56(6):427-429. doi: 10.1016/j.resinv.2018.08.008. Epub 2018 Oct 24.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers
  • Cell- and Tissue-Based Therapy
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Idiopathic Pulmonary Fibrosis* / diagnosis
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • Idiopathic Pulmonary Fibrosis* / physiopathology
  • Idiopathic Pulmonary Fibrosis* / therapy
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Male
  • Mesenchymal Stem Cells
  • Pyridones / pharmacology
  • Pyridones / therapeutic use
  • Respiratory Function Tests

Substances

  • Biomarkers
  • Indoles
  • Pyridones
  • pirfenidone
  • nintedanib